Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT07509775

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

Led by China-Japan Friendship Hospital · Updated on 2026-04-09

210

Participants Needed

1

Research Sites

127 weeks

Total Duration

On this page

Sponsors

C

China-Japan Friendship Hospital

Lead Sponsor

T

The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).

CONDITIONS

Official Title

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis
  • Age between 18 and 75 years
  • Sign informed consent
Not Eligible

You will not qualify if you...

  • Diagnosis of other autoimmune diseases besides the disease under investigation (e.g., rheumatoid arthritis, Sjögren's syndrome, erythema nodosum, myositis, etc.)
  • Pregnancy or lactation
  • Comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or malignancy
  • Spondyloarthritis related to enteropathic arthritis, psoriatic arthritis, or reactive arthritis
  • Unable to provide data due to mental, language, or similar factors

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

China-Japan Friendship Hospital

Beijing, Beijing, China, China, 100029

Actively Recruiting

Loading map...

Research Team

Y

Yuanyuan Zou, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here